Literature DB >> 20709005

Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.

Sangun Lee1, Boris R Belitsky, David W Brown, James P Brinker, Kathryn O Kerstein, John E Herrmann, Gerald T Keusch, Abraham L Sonenshein, Saul Tzipori.   

Abstract

Bacillus subtilis strains expressing tetanus toxin fragment C (TTFC) were tested as vaccine candidates against tetanus in adult mice. Mice received three intranasal (IN) exposures to 10(9) spores or 10(8) vegetative cells of B. subtilis expressing recombinant TTFC. Immunized mice generated protective systemic and mucosal antibodies and survived challenge with 2× LD(100) of tetanus toxin. Isotype analysis of serum antibody indicated a balanced Th1/Th2 response. Lyophilized vaccines stored at 45° C for ≥ 12 months, remained effective. Immunized conventional and SCID mice remained well, and no histological changes in brain or respiratory tract were detected. Lyophilized/reconstituted B. subtilis tetanus vaccines administered IN to mice appear safe, heat-stable, and protective against lethal tetanus challenge.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709005     DOI: 10.1016/j.vaccine.2010.08.016

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Mucosal vaccination against tuberculosis using inert bioparticles.

Authors:  Rajko Reljic; Laura Sibley; Jen-Min Huang; Ilaria Pepponi; Andreas Hoppe; Huynh A Hong; Simon M Cutting
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

2.  The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics.

Authors:  Jose M Suárez; Adrianne N Edwards; Shonna M McBride
Journal:  J Bacteriol       Date:  2013-03-29       Impact factor: 3.490

Review 3.  Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.

Authors:  Hellen Amuguni; Saul Tzipori
Journal:  Hum Vaccin Immunother       Date:  2012-06-15       Impact factor: 3.452

4.  Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens.

Authors:  Milene Tavares Batista; Renata D Souza; Juliano D Paccez; Wilson B Luiz; Ewerton L Ferreira; Rafael C M Cavalcante; Rita C C Ferreira; Luís C S Ferreira
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

5.  Comparative analysis of Bacillus subtilis spores and monophosphoryl lipid A as adjuvants of protein-based mycobacterium tuberculosis-based vaccines: partial requirement for interleukin-17a for induction of protective immunity.

Authors:  Sandra C Esparza-Gonzalez; Amber R Troy; Angelo A Izzo
Journal:  Clin Vaccine Immunol       Date:  2014-01-29

6.  Hard surface biocontrol in hospitals using microbial-based cleaning products.

Authors:  Alberta Vandini; Robin Temmerman; Alessia Frabetti; Elisabetta Caselli; Paola Antonioli; Pier Giorgio Balboni; Daniela Platano; Alessio Branchini; Sante Mazzacane
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

7.  Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency.

Authors:  Yeonsu Oh; Jung Ae Kim; Chang-Hwan Kim; Soo-Keun Choi; Jae-Gu Pan
Journal:  BMC Vet Res       Date:  2020-07-28       Impact factor: 2.741

Review 8.  Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions.

Authors:  Karin Hoelzer; Lisa Bielke; Damer P Blake; Eric Cox; Simon M Cutting; Bert Devriendt; Elisabeth Erlacher-Vindel; Evy Goossens; Kemal Karaca; Stephane Lemiere; Martin Metzner; Margot Raicek; Miquel Collell Suriñach; Nora M Wong; Cyril Gay; Filip Van Immerseel
Journal:  Vet Res       Date:  2018-07-31       Impact factor: 3.683

Review 9.  Probiotics, prebiotics, and the host microbiome: the science of translation.

Authors:  Bryon Petschow; Joël Doré; Patricia Hibberd; Timothy Dinan; Gregor Reid; Martin Blaser; Patrice D Cani; Fred H Degnan; Jane Foster; Glenn Gibson; John Hutton; Todd R Klaenhammer; Ruth Ley; Max Nieuwdorp; Bruno Pot; David Relman; Andrew Serazin; Mary Ellen Sanders
Journal:  Ann N Y Acad Sci       Date:  2013-11-22       Impact factor: 5.691

10.  Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys.

Authors:  Rui Yu; Ting Fang; Shuling Liu; Xiaohong Song; Changming Yu; Jianmin Li; Ling Fu; Lihua Hou; Junjie Xu; Wei Chen
Journal:  Toxins (Basel)       Date:  2016-06-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.